Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

APREA THERAPEUTICS, INC.

(APRE)
Real-time geschatte koers. Geschatte realtime Cboe BZX - 28/09 15:41:13
4.575 USD   -1.40%
22/09INSIDER SELL : Aprea Therapeutics
MT
20/08APREA THERAPEUTICS, INC. : JPMorgan Chase verlaagt advies naar Verkopen
MM
16/08APREA THERAPEUTICS, INC. : Berenberg Bank haalt aandeel van kooplijst
MM
OverzichtKoersenGrafiekenNieuwsRatingenAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op APREA THERAPEUTICS, INC.
22/09INSIDER SELL : Aprea Therapeutics
20/09APREA THERAPEUTICS : Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) in Advan..
20/09Aprea Therapeutics, Inc. Presents Data From Phase 1/2 Trial of Eprenetapopt (APR-246) i..
20/09Top Premarket Gainers
20/09APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from S&P Global BMI Index
14/09APREA THERAPEUTICS : to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Soli..
14/09Aprea Therapeutics to Present Data from Phase 1/2 Trial of Eprenetapopt in Advanced Sol..
23/08NORTH AMERICAN MORNING BRIEFING : Stock Furures -3-
16/08NORTH AMERICAN MORNING BRIEFING : Weak Chinese -4-
12/08APREA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resul..
12/08APREA THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Provides Update on ..
12/08APREA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Other Events, Fi..
12/08Aprea Therapeutics, Inc. Reports Unaudited Consolidated Earnings Results for the Second..
12/08Aprea Therapeutics Reports Second Quarter 2021 Financial Results and Provides Update on..
12/08APREA THERAPEUTICS : Says FDA Places Clinical Hold on Lymphoid Malignancy Program
12/08Aprea Therapeutics Announces Clinical Hold on Lymphoid Malignancy Program
12/08Aprea Therapeutics, Inc. Announces Clinical Hold on Lymphoid Malignancy Program
12/08APREA THERAPEUTICS : FDA Puts Clinical Hold on Lymphoid Malignancy Program
06/08SECTOR UPDATE : Health Care Pulls Back Ahead of Friday Opener
06/08Aprea Therapeutics Announces a Partial Clinical Hold on Myeloid Malignancy Programs
06/08APREA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
05/08APREA THERAPEUTICS : Announces a Partial Clinical Hold on Myeloid Malignancy Programs
21/07APREA THERAPEUTICS : Phase 2 Trial of Eprenetapopt With Azacitidine Yields Positive Result..
21/07APREA THERAPEUTICS : Announces Positive Results from Phase 2 Trial of Eprenetapopt + Azaci..
21/07Aprea Therapeutics, Inc. Announces Positive Results from Phase 2 Trial of Eprenetapopt ..
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell Small Cap Completeness Inde..
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell 2000 Dynamic Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell 3000E Growth Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell Microcap Growth Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell Small Cap Comp Growth Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell 2000 Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell 3000 Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) added to Russell Microcap Value Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) added to Russell 3000E Value Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell 3000E Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell 2500 Growth Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell 3000 Growth Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell 2000 Growth Index
25/06APREA THERAPEUTICS, INC.(NASDAQGS : APRE) dropped from Russell 2500 Index
16/06SECTOR UPDATE : Health Care Stocks Edging Lower at Close
16/06SECTOR UPDATE : Health Care Stocks Hanging On For Narrow Wednesday Gains
16/06Equities Little Changed in US Midday Trading as Markets Await Federal Reserve Rate Deci..
16/06MIDDAY REPORT : Wall Street Little Changed, Awaiting FOMC Outcome
16/06Wall Street Wavers Pre-Bell Ahead of FOMC Meeting
16/06SECTOR UPDATE : Health Care Stocks Mixed In Premarket Trading
16/06SECTOR UPDATE : Health Care
16/06APREA THERAPEUTICS : Says Phase 1/2 Trial of Combination Leukemia Treatment Met Primary En..
16/06APREA THERAPEUTICS : Announces Phase 1/2 Trial of Eprenetapopt + Venetoclax + Azacitidine ..
16/06Aprea Therapeutics Announces Phase 1/2 Trial of Eprenetapopt + Venetoclax + Azacitidine..
10/06APREA THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
21/05Aprea Therapeutics to Participate in the 2021 Oppenheimer Rare & Orphan Disease Summit
18/05Aprea Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Con..
06/05APREA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resul..
06/05APREA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statem..
06/05APREA THERAPEUTICS : Reports First Quarter 2021 Financial Results and Provides Update on B..
06/05Aprea Therapeutics, Inc. Announces Earnings Results for the Quarter Ended March 31, 202..
16/04Aprea Therapeutics to Host Virtual R&D Day on April 22, 2021
08/04SECTOR UPDATE : Health Care Stocks Drift Away from Midday Highs
08/04SECTOR UPDATE : Health Care Stocks Posting Modest Gains
08/04APREA THERAPEUTICS : Granted FDA Orphan Drug Designation for Eprenetapopt to Treat Leukemi..
08/04Aprea Therapeutics Receives FDA Orphan Drug Designation for Eprenetapopt for the Treatm..
16/03APREA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Resul..
16/03APREA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statem..
16/03Aprea Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Prov..
16/03Aprea Therapeutics, Inc. Announces Unaudited Consolidated Earnings Results for the Four..
16/03Aprea Therapeutics, Inc. Provides Update on Business Operations
12/01APREA THERAPEUTICS, INC. : Results of Operations and Financial Condition, Regulation FD Di..
08/01Aprea Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on T..
2020APREA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
2020APREA THERAPEUTICS : Says Late-Stage Trial of Cancer Treatment Failed to Meet Primary Endp..
2020APREA THERAPEUTICS : Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetap..
2020Aprea Therapeutics, Inc. Announces Results of Primary Endpoint from Phase 3 Trial of Ep..
2020APREA THERAPEUTICS, INC.(NASDAQGS : APRE) added to NASDAQ Biotechnology Index
2020APREA THERAPEUTICS : Secures FDA's Fast Track Designation for Acute Myeloid Leukemia Drug ..
2020Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatmen..
1  2Volgende
Volgende evenement op APREA THERAPEUTICS, INC.
18/11/21